Benjamin I. Perry

1.7k total citations
46 papers, 1.0k citations indexed

About

Benjamin I. Perry is a scholar working on Psychiatry and Mental health, Biological Psychiatry and Physiology. According to data from OpenAlex, Benjamin I. Perry has authored 46 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Psychiatry and Mental health, 18 papers in Biological Psychiatry and 10 papers in Physiology. Recurrent topics in Benjamin I. Perry's work include Tryptophan and brain disorders (18 papers), Schizophrenia research and treatment (16 papers) and Diet and metabolism studies (9 papers). Benjamin I. Perry is often cited by papers focused on Tryptophan and brain disorders (18 papers), Schizophrenia research and treatment (16 papers) and Diet and metabolism studies (9 papers). Benjamin I. Perry collaborates with scholars based in United Kingdom, Czechia and Portugal. Benjamin I. Perry's co-authors include Rachel Upthegrove, Golam M. Khandaker, Swaran P. Singh, Peter B. Jones, Stephen Burgess, Karen Rees, Scott Weich, Steven Marwaha, Stanley Zammit and Jayanta Chatterjee and has published in prestigious journals such as PLoS ONE, Brain and Scientific Reports.

In The Last Decade

Benjamin I. Perry

43 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Benjamin I. Perry United Kingdom 17 434 356 160 160 127 46 1.0k
Bartłomiej Stańczykiewicz Poland 19 451 1.0× 545 1.5× 230 1.4× 77 0.5× 226 1.8× 60 1.3k
Susanne Bengesser Austria 19 598 1.4× 501 1.4× 176 1.1× 96 0.6× 103 0.8× 83 1.2k
Sara Cherkerzian United States 22 246 0.6× 177 0.5× 69 0.4× 114 0.7× 220 1.7× 52 1.3k
Isabella Soreca United States 16 800 1.8× 231 0.6× 142 0.9× 105 0.7× 47 0.4× 29 1.2k
Ying-Sheue Chen Taiwan 19 609 1.4× 147 0.4× 156 1.0× 122 0.8× 84 0.7× 27 1.3k
Meihong Xiu China 18 509 1.2× 321 0.9× 141 0.9× 49 0.3× 107 0.8× 110 1.1k
Kai G. Kahl Germany 19 342 0.8× 216 0.6× 140 0.9× 45 0.3× 151 1.2× 60 1.2k
Margarita Rivera Spain 17 265 0.6× 152 0.4× 77 0.5× 215 1.3× 93 0.7× 34 1.0k
Patrick Hardy France 21 326 0.8× 157 0.4× 141 0.9× 100 0.6× 102 0.8× 47 1.4k
Merja Viikki Finland 20 300 0.7× 211 0.6× 92 0.6× 54 0.3× 102 0.8× 45 1.1k

Countries citing papers authored by Benjamin I. Perry

Since Specialization
Citations

This map shows the geographic impact of Benjamin I. Perry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Benjamin I. Perry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Benjamin I. Perry more than expected).

Fields of papers citing papers by Benjamin I. Perry

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Benjamin I. Perry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Benjamin I. Perry. The network helps show where Benjamin I. Perry may publish in the future.

Co-authorship network of co-authors of Benjamin I. Perry

This figure shows the co-authorship network connecting the top 25 collaborators of Benjamin I. Perry. A scholar is included among the top collaborators of Benjamin I. Perry based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Benjamin I. Perry. Benjamin I. Perry is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Lim, Wilson, Rajendra Lingala, Benjamin I. Perry, et al.. (2025). Structure–activity relationships of fenarimol analogues with potent in vitro and in vivo activity against Madurella mycetomatis , the main causative agent of mycetoma. RSC Medicinal Chemistry. 16(12). 6094–6108.
2.
Eskelinen, Saana, Tiina From, Heikki Laurikainen, et al.. (2024). Psychosis metabolic risk calculator ( PsyMetRiC ) in early psychosis: External validation study in Finland. Acta Psychiatrica Scandinavica. 151(1). 56–68. 1 indexed citations
3.
Formánek, Tomáš, Zdenĕk Šumnı́k, Karolína Mladá, et al.. (2024). Childhood-onset type 1 diabetes and subsequent adult psychiatric disorders: a nationwide cohort and genome-wide Mendelian randomization study. Nature Mental Health. 2(9). 1062–1070. 2 indexed citations
4.
Teasdale, Scott, Rachel Morell, Philip B. Ward, et al.. (2024). Metabolic syndrome risk prediction in an Australian sample with first-episode psychosis using the psychosis metabolic risk calculator: A validation study. Australasian Psychiatry. 33(1). 120–127.
5.
Formánek, Tomáš, Dzmitry Krupchanka, Benjamin I. Perry, et al.. (2024). Contribution of severe mental disorders to fatally harmful effects of physical disorders: national cohort study. The British Journal of Psychiatry. 225(4). 436–445. 2 indexed citations
7.
Mueller, Julia, Amy L. Ahern, Rebecca A. Jones, et al.. (2024). The relationship of within-individual and between-individual variation in mental health with bodyweight: An exploratory longitudinal study. PLoS ONE. 19(1). e0295117–e0295117. 1 indexed citations
8.
Osimo, Emanuele F., Benjamin I. Perry, Pavan Mallikarjun, et al.. (2023). Predicting treatment resistance from first-episode psychosis using routinely collected clinical information. Nature Mental Health. 1(1). 25–35. 14 indexed citations
9.
Osimo, Emanuele F., Luke Baxter, Jan Štochl, et al.. (2021). Longitudinal association between CRP levels and risk of psychosis: a meta-analysis of population-based cohort studies. Schizophrenia. 7(1). 31–31. 29 indexed citations
10.
Osimo, Emanuele F., Mark Sweeney, Antonio de Marvao, et al.. (2021). Adipose tissue dysfunction, inflammation, and insulin resistance: alternative pathways to cardiac remodelling in schizophrenia. A multimodal, case–control study. Translational Psychiatry. 11(1). 614–614. 15 indexed citations
11.
Perry, Benjamin I., Stephen Burgess, Hannah Jones, et al.. (2021). The potential shared role of inflammation in insulin resistance and schizophrenia: A bidirectional two-sample mendelian randomization study. PLoS Medicine. 18(3). e1003455–e1003455. 45 indexed citations
12.
Perry, Benjamin I., Emanuele F. Osimo, Rachel Upthegrove, et al.. (2021). Development and external validation of the Psychosis Metabolic Risk Calculator (PsyMetRiC): a cardiometabolic risk prediction algorithm for young people with psychosis. The Lancet Psychiatry. 8(7). 589–598. 28 indexed citations
13.
Perry, Benjamin I., Rachel Upthegrove, Seung-Ho Jang, et al.. (2020). Cardiometabolic risk prediction algorithms for young people with psychosis: a systematic review and exploratory analysis. Acta Psychiatrica Scandinavica. 142(3). 215–232. 13 indexed citations
14.
Osimo, Emanuele F., Benjamin I. Perry, Rudolf N. Cardinal, et al.. (2020). Inflammatory and cardiometabolic markers at presentation with first episode psychosis and long-term clinical outcomes: A longitudinal study using electronic health records. Brain Behavior and Immunity. 91. 117–127. 17 indexed citations
15.
Perry, Benjamin I., Golam M. Khandaker, Steven Marwaha, et al.. (2019). Insulin resistance and obesity, and their association with depression in relatively young people: findings from a large UK birth cohort. Psychological Medicine. 50(4). 556–565. 28 indexed citations
16.
Perry, Benjamin I., S. Cooray, Meena Dasari, et al.. (2018). Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross‐sectional survey. Journal of Intellectual Disability Research. 62(2). 140–149. 31 indexed citations
17.
Perry, Benjamin I., et al.. (2018). Stigma and access to care in first‐episode psychosis. Early Intervention in Psychiatry. 13(5). 1208–1213. 30 indexed citations
18.
Perry, Benjamin I., et al.. (2018). Use of a proforma to aid in reducing coercion into informal admission for acute adult psychiatric inpatients in the U.K.. Legal Medicine. 36. 103–109. 1 indexed citations
19.
Rowland, Tobias, Benjamin I. Perry, Rachel Upthegrove, et al.. (2018). Neurotrophins, cytokines, oxidative stress mediators and mood state in bipolar disorder: systematic review and meta-analyses. The British Journal of Psychiatry. 213(3). 514–525. 137 indexed citations
20.
Perry, Benjamin I., et al.. (2015). Prolactin monitoring in the acute psychiatry setting. Psychiatry Research. 235. 104–109. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026